Latest Multiplex Stories

POTOMAC FALLS, Va., April 25, 2013 /PRNewswire/ -- TessArae®, LLC and Kindstar Global, the largest esoteric reference laboratory in China, have signed a collaboration agreement for the development of a pan-ethnic carrier screen for the Chinese population. The assay, which will be run in Kindstar's laboratories in China, employs TessArae's targeted sequencing development platform and proprietary bioanalysis software. The agreement solidifies a development partnership which allows...

--Automated Multi-Tier ADA Test Combines Screening, Confirmatory and Isotyping Steps in a Single Assay-- SAN DIEGO, April 3, 2013 /PRNewswire/ -- Genalyte, Inc. today announced the launch of its MT-ADA(TM)( )anti-drug antibody (ADA) immunogenicity assay designed to run on the Maverick(TM) Detection System. This test combines screening for the presence of ADAs and the characterization of each detected ADA with a full isotype profile. With minimal required sample preparation and...

-Mokascience, Bucher Biotec and KRD Molecular Technologies will Distribute Maverick System and Genalyte Multiplex Assays in Selected European Territories- SAN DIEGO, March 26, 2013 /PRNewswire/ -- Genalyte, Inc. today announced its Maverick(TM)( )Detection System that simultaneously analyzes multiple antibodies and other proteins from a single small sample is now CE marked in Europe for research use. The company also reported its first European distribution agreements for the...

SAN DIEGO, Dec. 11, 2012 /PRNewswire/ -- Genalyte, Inc. today announced that it has been awarded a Small Business Innovation Research (SBIR) grant to develop multiplexed diagnostic assays for the early detection and monitoring of Type 1 diabetes that will run on Genalyte's innovative Maverick(TM)Detection System. The $500,000 grant is from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. Genalyte's novel...

LAUSANNE, Switzerland, December 5, 2012 /PRNewswire/ -- Biocartis launches its revolutionary detection platform, Dynamic Multi-Analyte Technology ("DMAT"): - New proteomic and nucleic acid platform provides ultra-high quality data analysis even at higher multiplex formats. - Platform launched well ahead of plan. Biocartis flips from a late-stage development company into a commercial business. Accurate and fast validation...

NEW YORK, Oct. 11, 2012 /PRNewswire/ -- Screenvision, a national leader in cinema advertising sales, services and content distribution, has signed an agreement with West Coast exhibitor partner, Krikorian Premiere Theatres, one of the world's grandest theatrical exhibition companies. Krikorian has seven locations with all 89 screens in the Los Angeles DMA (#2) and one 15-plex in the San Diego DMA (#28). This comes on the heels of Screenvision's long term partnership with Pacific...

SAN DIEGO, Sept. 24, 2012 /PRNewswire/ -- Genalyte, Inc. today announced that it is hosting a webinar to show participants how they can generate multiplexed autoantibody assay results in a one-step, 15 minute process. Genalyte's Maverick(TM) Detection System uses a silicon chip containing arrays of photonic ring sensors that simultaneously analyze multiple antibodies and other proteins from a single small sample. The webinar, Chip-Based Multiplex Autoantibody Detection, is...

SAN DIEGO and BERLIN, Sept. 19, 2012 /PRNewswire/ -- Genalyte, Inc., a life sciences company developing and commercializing innovative next generation multiplexing technology, and Scienion AG, a life science company developing microarray and ultra-low volume liquid handling systems, today announced an agreement under which Genalyte will market Scienion's sciFLEXARRAYER(TM)( )automated liquid dispensers along with Genalyte's multiplexed Maverick(TM )Detection System. The...

NEW YORK, Aug. 6, 2012 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX; TSX: IMX) and PVR Ltd. (PVR Cinemas), India's leading cinema brand and operator of the country's top-performing multiplexes, today announced an agreement to install an IMAX(®) theatre system in Bangalore that is scheduled to open by March 2013. The deal follows an earlier agreement with PVR Cinemas announced in March 2011 for four IMAX theatres, bringing the exhibitor's total IMAX commitment to five. Today's deal...

SAN DIEGO, July 24, 2012 /PRNewswire/ -- Genalyte, Inc., a life sciences company developing and commercializing innovative next generation multiplexing technology, today announced availability of the first assays for its Maverick(TM) Detection System -- the Maverick ENA 4 and ENA 6 Assay Kits. The assays simultaneously screen for several of the most common autoantibodies found in autoimmune connective tissue disorders, such as systemic lupus erythematosus (SLE). Their...